Thursday is November 12, the date the hemp ban was always supposed to start, and plenty of shoppers have it circled. They are watching the wrong date. What lands this week is a sliver: products made with cannabinoids the cannabis plant cannot produce at all. The ban that empties the shelf arrives a month later, on December 11, when total THC counts, a 0.4 milligram cap applies to every container, and lab-converted delta-8 stops being hemp.
Our read is the same one the hemp ban pillar has carried since September: plan around December 11, and treat a second delay as a surprise, not a plan. Congress has delayed this law once already, by 29 days, and the lame-duck session that returned on November 9 has until the same December 11 deadline to fund the government. Nothing it has done so far touches hemp.
What changes on November 12?
On November 12, 2026 hemp products stop qualifying as hemp under federal law if they contain cannabinoids that are not capable of being naturally produced by a Cannabis sativa plant. That is clause (I) of the new definition, and under Section 2019 of H.R. 6500 it is the only part of Section 781 that applies before December 11.
The statute itself names no compounds, and neither will we. The FDA was told to publish lists of what the plant can and cannot make, and the category is narrow enough that most people buying gummies at a smoke shop will not notice Thursday happened. Delta-9 from hemp, THCA, CBD and converted delta-8 all occur in the plant, so all of them keep their current federal status for four more weeks.
The exception is your state. State laws written around the original date did not move when Congress moved the federal one, so Missouri and Illinois close most hemp THC sales on November 12 regardless (the Missouri piece has what goes there and what keeps until December).
What changes on December 11?
On December 11, 2026 the whole Section 781 definition applies. Hemp is measured by total THC, THCA included, at 0.3 percent dry weight. Final products lose hemp status above 0.4 milligrams of total THC per container. And cannabinoids the plant can make but that were synthesized or manufactured outside it, which covers commercial delta-8, are excluded.
Take those three in order, because each one closes a different door.
Total THC. The 2018 Farm Bill measured delta-9 alone, which is how THCA flower got sold as hemp: the THCA reads as nothing until you heat it, and then it is THC. The new definition counts tetrahydrocannabinolic acid in the total. A plant that passed on December 10 because nobody counted its THCA fails on December 11 because somebody does.
The container cap. This is the rule that ends hemp edibles as a category. A final hemp-derived product cannot hold more than 0.4 milligrams of total THC, plus any cannabinoid with similar effects, per container. The statute defines a container as the innermost wrapping, packaging or vessel in direct contact with the product, enclosed for retail sale, and lists a jar, bottle, bag, box, packet, can, carton or cartridge as examples. Bulk shipping cases and outer wrappings the retail sale does not need are left out. So the cap applies to the pouch, not the gummy and not the pallet. For scale, the Post and Courier reports that gummies sold in South Carolina's independent pharmacies typically carry 10 or 25 milligrams each. A single 10 milligram piece is 25 times the limit for the entire bag, and a 25 milligram piece is more than 60 times it.
Made outside the plant. Clause (II) excludes cannabinoids that are capable of being naturally produced by the plant but were synthesized or manufactured outside it. Delta-8 occurs in cannabis in trace amounts, and the delta-8 in a gas station gummy was almost certainly converted from CBD in a reactor. That is why delta-8 belongs to December 11 and not November 12, a distinction a fair amount of local coverage this week has gotten backwards. The delta-8 page covers the chemistry and the state-by-state picture.
None of this comes with a sell-through window. Section 781 contains no inventory provision and no transition clause, and Section 2019 changed the date and nothing else, as we wrote when the delay was signed. If you want to know where a specific product lands, check a specific product against the statute before you buy more of it.
What doesn't change
Dispensary edibles. Section 781 rewrites the federal definition of hemp in the Agricultural Marketing Act and never mentions state cannabis programs, so a gummy bought at a state-licensed store was never hemp and is untouched on both dates. The dispensary directory covers 14 states.
What are hemp buyers doing before December 11?
Some are stocking up, and some sellers are encouraging it. A beverage maker reports bulk home deliveries, a South Carolina shopper told her local paper she would buy a year's supply, a Florida seller is running a 70 percent off sale, and an Austin retailer is telling customers to hold two to three months of product. The licensed alternative often costs less.
The clearest numbers come from Crescent Canna, a hemp seltzer maker. CEO Joe Gerrity told Forbes the company started offering 50-case orders freighted to customers' homes and took roughly forty in four or five days, mostly from existing customers who used to buy about four cases at a time. "Basically, people are getting pallets at their house," he said. Crescent is also holding about three months of stock in case Congress strikes a deal, which tells you how the people selling the product are hedging.
In Charleston, the Post and Courier found Terrie Johnson, 65, who started on delta-8 gummies for hip pain that was keeping her awake. She said $50 buys more than she uses in three months, and that she will probably buy a year's supply because of the ban. The same story reports that Florida-based Cannabis Life has halted production and is advertising a 70 percent off sale this month, and that Bottles Beverage Superstore plans to sell THC drinks right up to December 11. In Austin, Restart CBD published its own advice on November 9: buy a two to three month supply of anything you rely on while it is still on the shelf.
The other move is sideways, into the licensed channel, and the price comparison is less painful than the hemp marketing suggested. On November 10, Purple Star in San Francisco listed Wyld Elderberry, 10 gummies at 10 milligrams of THC and 5 of CBN each, at $18.00 on its Leafly menu. The same day, Wyld's own hemp site sold the Wyld Hemp Elderberry ten-pack, the same dose on the label, for $29.95. The version that loses its federal status in a month costs more than the version that does not.
Should you stockpile hemp edibles before the ban?
We would not. Stockpiling is clearly happening, and we understand why, but a drawer of hemp gummies is a poor bridge. THC degrades in storage, the dose you calibrated drifts as it does, and after December 11 that drawer is a legal question in your own state that federal law does nothing to answer.
The degradation point is not theoretical. Our shelf-life guide walks through how the THC in a gummy fades on a different clock from the gummy itself, which matters most to exactly the person buying a year's supply: someone who found a dose that works and wants it to keep working. Months in, the 10 milligram gummy is no longer quite a 10 milligram gummy, and there is no label to tell you by how much. The legal point is simpler. Section 781 has no grandfather clause, and it does not care when you bought the product. If your state already treats hemp THC as marijuana, or does from December 11, the stockpile becomes the problem.
That leaves three real options, the same ones the pillar lays out. In an adult-use state, switch to a dispensary now, while your current product is still around to compare against. In a medical-only state, apply for a card now, since processing takes weeks. In a state with neither, CBD isolate under the container cap stays legal and THC does not.
Who loses the most when the hemp ban lands?
People using hemp products for pain, anxiety and sleep, in states without a dispensary program. In a 2,409-person CBD survey by Corroon and Phillips (2018) and a delta-8 consumer survey by Kruger and Kruger (2023), pain and anxiety led the reasons for use, with sleep behind them. Those buyers have no licensed counter to switch to.
The Post and Courier's reporting reads like the surveys come to life. A wellness counselor at a Mount Pleasant pharmacy called hemp THC probably the store's biggest product and said customers use it for pain. Many of that pharmacy's customers, the paper reports, are older residents treating pain, anxiety and sleeplessness. South Carolina has no medical program to send them to.
For readers in states that do have one, the anxiety switch deserves more care than the others. In the Childs, Lutz and de Wit (2017) stress trial in Drug and Alcohol Dependence, 7.5 milligrams of oral THC lowered distress and 12.5 milligrams raised it, five milligrams apart, which is a narrow window for someone coming off a 25 milligram hemp gummy. Our generalized anxiety page covers that trial and the rest of the evidence, and the anxiety rankings lean toward higher CBD ratios for the same reason.
What to watch before December 11
One vehicle and three outcomes. The funding bill due December 11 is the only realistic carrier for hemp language this year, as it was in September. It can let the ban land in full, delay it again, or swap the ban for a product-regulation system along the lines of the bills already filed, none of which has had a hearing. Foley Hoag reported in September that White House legislative affairs director James Braid committed to no further extensions beyond December 11; the same post notes he was reported to be leaving the administration that month, and nobody has put the promise in writing since. Until a bill text moves, December 11 is the date.